Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
No element in selection
Contact

1 result

Type : Health technology assessment
Topics : Male genital diseases
Topics : Genital cancers
Topics : Genital diseases
Topics : Biology (laboratory tests)
Active substance : cyclophosphamide

Topic

Diagnostic and therapeutic techniques (1)
Plus ...
- Diagnostic techniques and procedures (1)
- Plus ...
  - Biology (laboratory tests) (1)
Diseases and conditions (1)
Plus ...
Population groups (1)
Plus ...
- Paediatrics (1)

Drugs, devices and medical acts (1)
Plus ...
- Health technology assessment (1)

Date

Last five years (1)

Français (1)

Active substance

cyclophosphamide (1)
mannitol (1)

Première page
Page précédente
/ 1
Page suivante
Dernière page

Sorted by :Title

Relevance
Date

Assessment of anti-Müllerian hormone serum assay - INAHTA Brief

Health technology assessment - Posted on 26/07/2017

Download document

Add to my selection

Première page
Page précédente
/ 1
Page suivante
Dernière page
10 par pages

Advancing quality in the fields of health and social care services

Follow us :

Eunetha.eu
Pasq.eu

All our publications by topic and type

Opinions on medicines
Opinions on medical devices
INAHTA briefs

Français
English

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

WBfqkauDr44DfMUr